Sunday, 20 June 2021


Singapore authorises four COVID-19 antigen rapid test self-use kits

11 June 2021 | News

HSA is working with the Ministry of Health (MOH) to make these tests widely available through designated local retail pharmacies

Image credit- SD Biosensor

Image credit- SD Biosensor

The Health Sciences Authority (HSA) in Singapore has granted interim authorisation for the following four antigen rapid test self-test kits:

Name of antigen rapid test self-test kit

Name of distributor

Authorisation date

Abbott PanBioTM COVID-19 Antigen Self-Test

Unison Collaborative Pte Ltd

31 May 2021

Quidel QuickVue At-Home OTC COVID-19 Test

Quantum Technologies Global Pte Ltd

2 June 2021

SD Biosensor SARS-CoV-2 Antigen Self-Test Nasal

Roche Diagnostics Asia Pacific Pte Ltd

9 June 2021

SD Biosensor Standard Q COVID-19 Ag Home Test

SPD Scientific Pte Ltd

9 June 2021

 

These are antigen rapid tests (ARTs) that can be used by consumers (untrained lay-users) for self-testing to detect active SARS-CoV-2 infection in nasal swab samples. ARTs detect the viral proteins in the nasal swab samples of infected individuals and usually work best in the early stages of infection. In general, ARTs can achieve a sensitivity of about 80% for cases with higher viral loads and a specificity range of 97-100%.

 If a positive result is received from the self-test, users should follow MOH’s guidelines on the next steps to take.

As these tests are meant for use by consumers, they can be bought by consumers without a doctor’s prescription. HSA is working with the Ministry of Health (MOH) to make these tests widely available through designated local retail pharmacies from 16 June 2021 and will be made available at more retail locations progressively.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account